Beverages - Non-alcoholic · Consumer Defensive · Fiscal year ends Dec 31 · Reports in CLP
Andina Bottling reported revenue of CLP 3,345B in the fiscal year ended Dec 2025, up 3.7% from the year before. Operating income was CLP 449B, an operating margin of 13.4%, and net income was CLP 270B. Operating cash flow of CLP 461B less capital expenditure of CLP 278B left free cash flow of CLP 183B.
Ranks among the 12 beverages - non-alcoholic companies we cover (1st = best; for debt, the least indebted). Green = top third, red = bottom third.
Last 5 fiscal years
| Fiscal year | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 2,216,733 | 2,656,878 | 2,618,437 | 3,224,233 | 3,344,836 |
| Cost of revenue | 1,375,393 | 1,628,702 | 1,601,997 | 1,945,363 | 2,037,679 |
| Gross profit | 841,340 | 1,028,177 | 1,016,440 | 1,278,870 | 1,307,157 |
| Operating incomederived: pre-tax income + interest | 256,201 | 292,352 | 325,794 | 438,451 | 448,853 |
| Interest expense | 52,992 | 59,548 | 65,288 | 70,414 | 68,218 |
| Pre-tax income | 203,209 | 232,804 | 260,506 | 368,037 | 380,634 |
| Income tax | 46,177 | 104,345 | 85,994 | 133,393 | 110,157 |
| Net income | 157,032 | 128,459 | 174,511 | 234,644 | 270,477 |
| Diluted EPS | 163.43 | 132.58 | 181.12 | 245.80 | 283.86 |
| Diluted shares | 947 | 947 | 947 | 947 | 947 |
| Fiscal year | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Cash & equivalents | 304,312 | 291,682 | 303,684 | 248,899 | 296,540 |
| Receivables | 265,491 | 279,770 | 298,892 | 332,831 | 339,778 |
| Current assets | 990,986 | 1,161,729 | 981,771 | 1,013,196 | 1,033,053 |
| Net PP&E | 716,379 | 798,221 | 872,389 | 1,097,774 | 1,179,385 |
| Goodwill | 118,043 | 129,024 | 122,104 | 144,681 | 137,128 |
| Total assets | 2,946,107 | 3,010,701 | 2,921,521 | 3,291,104 | 3,420,405 |
| Payables | 327,409 | 384,802 | 428,912 | 457,075 | 480,396 |
| Current liabilities | 529,567 | 949,245 | 692,871 | 906,144 | 730,413 |
| Total liabilities | 1,844,693 | 2,127,298 | 2,000,535 | 2,276,707 | 2,223,852 |
| Shareholders' equity | 1,076,144 | 855,260 | 886,291 | 976,409 | 1,157,399 |
| Fiscal year | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Operating cash flow | 305,055 | 397,452 | 366,830 | 357,242 | 461,127 |
| Capital expenditure | 138,856 | 186,702 | 192,707 | 291,542 | 277,822 |
| Free cash flow | 166,199 | 210,750 | 174,123 | 65,700 | 183,305 |
| Depreciation & amortisation | 104,775 | 119,365 | 112,771 | 151,111 | 159,241 |
| Dividends paid | 106,347 | 274,316 | 165,877 | 158,408 | 195,890 |
| Fiscal year | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Revenue growth (YoY) | – | 19.9% | −1.4% | 23.1% | 3.7% |
| Operating income growth (YoY) | – | 14.1% | 11.4% | 34.6% | 2.4% |
| EPS growth (YoY) | – | −18.9% | 36.6% | 35.7% | 15.5% |
| Gross margin | 38.0% | 38.7% | 38.8% | 39.7% | 39.1% |
| Operating margin | 11.6% | 11.0% | 12.4% | 13.6% | 13.4% |
| Net margin | 7.1% | 4.8% | 6.7% | 7.3% | 8.1% |
| Return on equityBlank when equity is negative | 14.6% | 15.0% | 19.7% | 24.0% | 23.4% |
| ROCEEBIT ÷ (assets − current liabilities) | 10.6% | 14.2% | 14.6% | 18.4% | 16.7% |
| Free cash flow margin | 7.5% | 7.9% | 6.6% | 2.0% | 5.5% |
| Cash conversion (CFO ÷ net income) | 1.94x | 3.09x | 2.10x | 1.52x | 1.70x |
| Receivable days | 44 | 38 | 42 | 38 | 37 |
| Payable days | 87 | 86 | 98 | 86 | 86 |
| Interest cover | 4.83x | 4.91x | 4.99x | 6.23x | 6.58x |
| Current ratio | 1.87x | 1.22x | 1.42x | 1.12x | 1.41x |
Standardised figures from the company's XBRL filings with the SEC (10-K, 10-Q). Line items follow US GAAP tags, so a company's own statement layout may differ and some lines show “–” where the company does not report that item. Ratios are calculated from these figures. For education only; not investment advice or a recommendation.